Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Hot Stocks
Y-mAbs Therapeutics CFO Bo Kruse resigns » 09:07
03/14/24
03/14
09:07
03/14/24
09:07
YMAB

Y-mAbs Therapeutics

$15.85 /

-0.22 (-1.37%)

Y-mAbs Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Y-mAbs Therapeutics price target raised by $1 at H.C. Wainwright, here's why » 06:13
03/06/24
03/06
06:13
03/06/24
06:13
YMAB

Y-mAbs Therapeutics

$16.65 /

-0.7 (-4.03%)

H.C. Wainwright raised…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Biotech Alert: Searches spiking for these stocks today » 10:50
03/04/24
03/04
10:50
03/04/24
10:50
JAGX

Jaguar Health

/

+

, YMAB

Y-mAbs Therapeutics

$18.23 /

-0.445 (-2.38%)

, ADIL

Adial Pharmaceuticals

$3.02 /

-0.17 (-5.33%)

, ALDX

Aldeyra

$4.11 /

-0.11 (-2.61%)

, DTIL

Precision BioSciences

$12.38 /

-0.17 (-1.35%)

These names in the…

Open Full Text

Recommendations
Y-mAbs Therapeutics price target raised by $10 at BMO Capital, here's why » 08:43
03/04/24
03/04
08:43
03/04/24
08:43
YMAB

Y-mAbs Therapeutics

$18.68 /

+2.005 (+12.03%)

BMO Capital raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Y-mAbs Therapeutics appoints Tagliaferri to board of directors » 07:36
03/04/24
03/04
07:36
03/04/24
07:36
YMAB

Y-mAbs Therapeutics

$18.68 /

+2.005 (+12.03%)

, NKTR

Nektar

/

+

Y-mAbs Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Y-mAbs Therapeutics price target raised by $4 at Canaccord, here's why » 07:32
03/04/24
03/04
07:32
03/04/24
07:32
YMAB

Y-mAbs Therapeutics

$18.68 /

+2.005 (+12.03%)

Canaccord analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Y-mAbs Therapeutics sees FY24 revenue $95M-$100M, consensus $96.27M » 16:23
02/29/24
02/29
16:23
02/29/24
16:23
YMAB

Y-mAbs Therapeutics

$16.67 /

+0.4 (+2.46%)

Sees FY24 operating…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Y-mAbs Therapeutics reports Q4 EPS (2c), consensus (20c) » 16:22
02/29/24
02/29
16:22
02/29/24
16:22
YMAB

Y-mAbs Therapeutics

$16.67 /

+0.4 (+2.46%)

Reports Q4 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Y-mAbs Therapeutics price target raised by $10 at H.C. Wainwright, here's why » 06:16
02/20/24
02/20
06:16
02/20/24
06:16
YMAB

Y-mAbs Therapeutics

$16.31 /

+0.195 (+1.21%)

H.C. Wainwright raised…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Biotech Alert: Searches spiking for these stocks today » 10:56
01/31/24
01/31
10:56
01/31/24
10:56
FGEN

FibroGen

$1.68 /

-0.03 (-1.75%)

, FATE

Fate Therapeutics

$5.81 /

+0.215 (+3.84%)

, PTN

Palatin

$4.73 /

-0.105 (-2.17%)

, NBY

NovaBay

/

+

, YMAB

Y-mAbs Therapeutics

$12.53 /

-0.02 (-0.16%)

, CKPT

Checkpoint Therapeutics

$1.98 /

+0.1 (+5.32%)

, AKBA

Akebia

$1.65 /

+0.01 (+0.61%)

, CLRB

Cellectar Biosciences

$4.06 /

+0.105 (+2.65%)

These names in the…

Open Full Text

Over a quarter ago
On The Fly
Fly Intel: After-Hours Movers » 18:33
12/13/23
12/13
18:33
12/13/23
18:33
YMAB

Y-mAbs Therapeutics

$6.84 /

+0.14 (+2.09%)

, CDXS

Codexis

$2.10 /

+0.11 (+5.53%)

, CHSN

Chanson International

$14.37 /

+3.23 (+28.99%)

, ASYS

Amtech Systems

$6.00 /

+ (+0.00%)

, MIND

Mind Technology

$5.68 /

+0.24 (+4.41%)

, ADBE

Adobe

$623.89 /

-9.69 (-1.53%)

, OCUL

Ocular Therapeutix

$3.94 /

+0.435 (+12.41%)

, RGS

Regis

$9.25 /

+0.44 (+4.99%)

, ASLE

AerSale

$14.76 /

+0.29 (+2.00%)

Check out this evening's…

Open Full Text

Earnings
Y-mAbs Therapeutics sees FY23 DANYELZA revenue $80M- $85M, consensus $83.67M » 16:29
11/13/23
11/13
16:29
11/13/23
16:29
YMAB

Y-mAbs Therapeutics

$4.90 /

-0.15 (-2.97%)

Reiterating anticipated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Y-mAbs Therapeutics reports Q3 EPS (18c), consensus (19c) » 16:26
11/13/23
11/13
16:26
11/13/23
16:26
YMAB

Y-mAbs Therapeutics

$4.90 /

-0.15 (-2.97%)

Reports Q3 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Y-mAbs Therapeutics appoints Michael Rossi as CEO » 16:11
10/18/23
10/18
16:11
10/18/23
16:11
YMAB

Y-mAbs Therapeutics

$5.34 /

-0.01 (-0.19%)

, MIR

Mirion

$7.22 /

-0.115 (-1.57%)

Y-mAbs Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Y-mAbs Therapeutics announces FDA clearance of CD38-SADA IND application » 16:07
10/17/23
10/17
16:07
10/17/23
16:07
YMAB

Y-mAbs Therapeutics

$5.35 /

-0.01 (-0.19%)

Y-mAbs Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Y-mAbs announces publication of naxitamab-based chemoimmunotherapy data » 16:12
10/16/23
10/16
16:12
10/16/23
16:12
YMAB

Y-mAbs Therapeutics

$5.37 /

+0.11 (+2.09%)

Y-mAbs Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Y-mAbs Therapeutics price target lowered to $7 from $8 at JPMorgan » 10:32
08/22/23
08/22
10:32
08/22/23
10:32
YMAB

Y-mAbs Therapeutics

$5.83 /

-0.31 (-5.05%)

JPMorgan lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Y-mAbs Therapeutics price target lowered to $5 from $7 at Morgan Stanley » 07:46
08/14/23
08/14
07:46
08/14/23
07:46
YMAB

Y-mAbs Therapeutics

$5.55 /

-0.62 (-10.06%)

Morgan Stanley analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Y-mAbs Therapeutics reports Q2 EPS (14c), consensus (24c) » 16:19
08/10/23
08/10
16:19
08/10/23
16:19
YMAB

Y-mAbs Therapeutics

$6.17 /

+0.33 (+5.66%)

Reports Q2 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Y-mAbs Therapeutics price target raised to $22 from $21 at Canaccord » 06:48
07/25/23
07/25
06:48
07/25/23
06:48
YMAB

Y-mAbs Therapeutics

$6.25 /

-0.375 (-5.66%)

Canaccord analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Y-mAbs Therapeutics announces presentation of GD2-SADA study at ASCO » 09:02
05/26/23
05/26
09:02
05/26/23
09:02
YMAB

Y-mAbs Therapeutics

$8.99 /

-0.65 (-6.74%)

Y-mAbs Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Y-mAbs Therapeutics announces presentation of naxitamab data at ASCO » 09:01
05/26/23
05/26
09:01
05/26/23
09:01
YMAB

Y-mAbs Therapeutics

$8.99 /

-0.65 (-6.74%)

Y-mAbs Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Y-mAbs Therapeutics announces approval of DANYELZA in Brazil » 09:05
05/23/23
05/23
09:05
05/23/23
09:05
YMAB

Y-mAbs Therapeutics

$9.57 /

-0.12 (-1.24%)

Y-mAbs Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Y-mAbs Therapeutics director buys $981K in common stock » 17:11
05/17/23
05/17
17:11
05/17/23
17:11
YMAB

Y-mAbs Therapeutics

$9.53 /

-0.51 (-5.08%)

In a regulatory filing,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Y-mAbs Therapeutics price target raised to $12 from $6 at BofA » 08:11
05/15/23
05/15
08:11
05/15/23
08:11
YMAB

Y-mAbs Therapeutics

$8.98 /

-0.21 (-2.29%)

BofA analyst Alec…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Upgrade
Wedbush upgrades Y-mAbs Therapeutics to Outperform, raises price target to $13 » 07:39
05/10/23
05/10
07:39
05/10/23
07:39
YMAB

Y-mAbs Therapeutics

$9.26 /

+2.53 (+37.59%)

As previously reported,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Upgrade
Y-mAbs Therapeutics upgraded to Outperform from Neutral at Wedbush » 06:30
05/10/23
05/10
06:30
05/10/23
06:30
YMAB

Y-mAbs Therapeutics

$9.26 /

+2.53 (+37.59%)

Wedbush upgraded Y-mAbs…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Y-mAbs Therapeutics price target raised to $21 from $18 at Canaccord » 06:48
05/09/23
05/09
06:48
05/09/23
06:48
YMAB

Y-mAbs Therapeutics

$6.74 /

-0.18 (-2.60%)

Canaccord analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Y-mAbs Therapeutics reports Q1 EPS (15c), consensus (32c) » 16:07
05/08/23
05/08
16:07
05/08/23
16:07
YMAB

Y-mAbs Therapeutics

$6.74 /

-0.18 (-2.60%)

Reports Q1 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.